MedTrace Logo

Project JAY THA Registration Study

NCT02347384 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-11-14

No results posted yet for this study

Summary

This is a prospective, randomized, multicenter clinical study in Chinese subjects to compare the safety and efficacy of the Delta PLUS Femoral Head and SL-TWIN Stem with BIOLOX forte ball head and SL-PLUS Stem in total hip arthroplasty

Conditions

Interventions

DEVICE

Delta PLUS Femoral Head + SL-TWIN Stem

Subject will undergo total hip arthroplasty with Delta PLUS Femoral Head \& SL-TWIN Stem

DEVICE

BIOLOX forte ball head + SL-PLUS Stem

Subject will undergo total hip arthroplasty with BIOLOX forte ball head \& SL-PLUS Stem

Sponsors & Collaborators

  • Smith & Nephew Orthopaedics (Beijing) Limited

    lead INDUSTRY

Principal Investigators

  • Li Cao · First Affiliated Hospital of Xinjiang Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-20
Primary Completion
2016-11-01
Completion
2016-11-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02347384 on ClinicalTrials.gov